赖氨酸安非他命
赖氨酸安非他命(英語:),是中樞神經系統(CNS)右旋安非他命刺激剂的前体药物,一种安非他命类的苯乙胺衍生物,用于治疗注意力不足過動症(ADHD)和過胖暴食症。本药品为右旋安非他命和赖氨酸形成的酰胺。[4][5]
臨床資料 | |
---|---|
其他名稱 | Vyvanse |
AHFS/Drugs.com | Monograph |
MedlinePlus | a607047 |
核准狀況 | |
懷孕分級 |
|
依賴性 | 身体依赖: 无 精神依赖: 中等 |
成癮性 | 中等 |
给药途径 | 口服(胶囊) |
ATC碼 | |
法律規範狀態 | |
法律規範 |
|
藥物動力學數據 | |
生物利用度 | 96.4%[1] |
药物代谢 | 起初由红血球水解。 余下的代谢过程同安非他命#藥物代謝動力學。 |
藥效起始時間 | 2小时[2][3] |
生物半衰期 | ≤1小时(前体药物分子) 9至11小时(右旋安非他命) |
作用時間 | 12 hours[2][3] |
排泄途徑 | 肾脏:约2% |
识别 | |
| |
CAS号 | 608137-32-2 [IUPHAR] |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
化学 | |
化学式 | C15H25N3O |
摩尔质量 | 263.378 g/mol |
3D模型(JSmol) | |
| |
|
参考资料
- (PDF). Shire Pharmaceuticals Contracts Limited: 14. [2014-08-23]. (原始内容存档 (PDF)于2014-08-26).
- Millichap JG. . Millichap JG (编). 2nd. New York, USA: Springer. 2010: 112. ISBN 9781441913968.
Table 9.2 Dextroamphetamine formulations of stimulant medication
Dexedrine [Peak:2–3 h] [Duration:5–6 h] ...
Adderall [Peak:2–3 h] [Duration:5–7 h]
Dexedrine spansules [Peak:7–8 h] [Duration:12 h] ...
Adderall XR [Peak:7–8 h] [Duration:12 h]
Vyvanse [Peak:3–4 h] [Duration:12 h] - Brams, Matthew; Mao, Alice R.; Doyle, Robert L. . Postgraduate Medicine. 2008-01, 120 (3): 69–88. ISSN 0032-5481. PMID 18824827. doi:10.3810/pgm.2008.09.1909 (英语).
Onset of efficacy was earliest for d-MPH-ER at 0.5 hours, followed by d, l-MPH-LA at 1 to 2 hours, MCD at 1.5 hours, d, l-MPH-OR at 1 to 2 hours, MAS-XR at 1.5 to 2 hours, MTS at 2 hours, and LDX at approximately 2 hours. ... MAS-XR, and LDX have a long duration of action at 12 hours postdose
- (PDF). United States Food and Drug Administration. Shire US Inc. January 2015 [2015-02-24]. (原始内容存档 (PDF)于2015-02-25).
- Heal, David J; Smith, Sharon L; Gosden, Jane; Nutt, David J. . Journal of Psychopharmacology. 2013-06, 27 (6): 479–496 [2022-05-09]. ISSN 0269-8811. PMC 3666194 . PMID 23539642. doi:10.1177/0269881113482532. (原始内容存档于2022-01-05) (英语).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.